NewsRx

Search our medical news database

Celgene Corporation

Celgene Reports Record Fourth Quarter and Full Year 2009 Product Sales and Operating Income

Published in Medical Letter on the CDC and FDA, February 14th, 2010

Celgene Corporation (NASDAQ: CELG): 2009 Fourth Quarter Financial Results Year-Over-Year: Non-GAAP Total Revenue Increased 22 Percent to $758 Million; GAAP Total Revenue $761 Million

Global REVLIMID Net Product Sales Increased 35 Percent to $497 Million

Global VIDAZA Net Product Sales Increased 68 Percent to $117 Million

Global THALOMID® Net Product Sales of $108 Million

Non-GAAP Operating Income Increased 48 Percent to $337 Million; GAAP Operating Income $283 Million

Non-GAAP Net Income Increased to $290 Million; GAAP Net Income $254 Million

Non-GAAP Diluted...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook